Life Sciences

Vietnam Gives Green Light to First African Swine Fever Vaccines

Vietnam Gives Green Light to First African Swine Fever ...

Jul 27, 2023

According to a statement released by the government on Monday, Vietnam has given...

FDA approves Tarsus’ Xdemvy, the first treatment for a prevalent eyelid condition

FDA approves Tarsus’ Xdemvy, the first treatment for a ...

Jul 27, 2023

Tarsus Pharmaceuticals has achieved a significant milestone with the FDA approva...

Verrica Scores FDA Approval for Ycanth at the Cost of a Drop in Share Value

Verrica Scores FDA Approval for Ycanth at the Cost of a...

Jul 27, 2023

Verrica Pharmaceuticals has finally obtained approval from the Food and Drug Adm...

Bavarian Nordic Fails Phase 3 Trial, Leaving the RSV Race

Bavarian Nordic Fails Phase 3 Trial, Leaving the RSV Race

Jul 27, 2023

Bavarian Nordic, a Danish pharmaceutical company, suffered a significant setback...

Mirati’s KRAS Inhibitor Krazi Fails to Make It in Europe

Mirati’s KRAS Inhibitor Krazi Fails to Make It in Europe

Jul 25, 2023

Mirati Therapeutics has learned the hard way that a clearance from the U.S. Food...

American Society of Retinal Specialists raise concerns regarding Apellis Pharmaceuticals’ Syfovre

American Society of Retinal Specialists raise concerns ...

Jul 25, 2023

The American Society of Retinal Specialists (ASRS) issued a letter to doctors ra...

FDA approves MeMed’s bacteria-versus-virus blood test to the point of care

FDA approves MeMed’s bacteria-versus-virus blood test t...

Jul 25, 2023

MeMed, an infectious disease diagnostic company, has achieved a significant mile...

ADC Therapeutics terminates Zynlonta study after FDA puts a hold

ADC Therapeutics terminates Zynlonta study after FDA pu...

Jul 25, 2023

ADC Therapeutics has decided to terminate its Zynlonta trial after the FDA impos...

Novartis Acquires DTx Pharma in a Deal Potentially Worth $1B

Novartis Acquires DTx Pharma in a Deal Potentially Wort...

Jul 21, 2023

Swiss pharmaceutical firm Novartis said on Monday that it has purchased biotechn...

BridgeBio’s acoramidis shows positive results in phase 3 trial for heart disease

BridgeBio’s acoramidis shows positive results in phase ...

Jul 21, 2023

Late-stage study results from BridgeBio’s phase 3 trial of its heart disease dru...

Alnylam’s RNAi approach reaches the biomarker target

Alnylam’s RNAi approach reaches the biomarker target

Jul 21, 2023

Alnylam has made significant progress in combating Alzheimer’s disease using its...

Pharmaceutical Layoffs Begin as FibroGen And Boston Sciences Cut Down Staff

Pharmaceutical Layoffs Begin as FibroGen And Boston Sci...

Jul 21, 2023

It seems like pharmaceutical layoffs are in full flow as FibroGen and Boston Sci...

Sanofi and AstraZeneca Receive US Approval for Infant RSV Drug Beyfortus

Sanofi and AstraZeneca Receive US Approval for Infant R...

Jul 21, 2023

Sanofi and AstraZeneca have obtained approval from the US Food and Drug Administ...

BMS expansion into neurodegeneration space with $95 million partnership

BMS expansion into neurodegeneration space with $95 mil...

Jul 19, 2023

Bristol Myers Squibb has expanded into the neuroscience sector with its updated ...

Expansion of Novartis’ Beacon of Hope Initiative

Expansion of Novartis’ Beacon of Hope Initiative

Jul 19, 2023

Novartis and the Novartis US Foundation have undergone a substantial expansion o...

Acumen’s Next-Gen Leqembi Rival Shows Promise in Early Alzheimer’s Data

Acumen’s Next-Gen Leqembi Rival Shows Promise in Early ...

Jul 17, 2023

Acumen Pharmaceuticals recently unveiled early clinical evidence showcasing the ...

31
32
33
34
35